Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study.

MLA

Abello, Virginia, et al. “Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study.” Clinical Lymphoma, Myeloma & Leukemia, vol. 22, no. 6, June 2022, pp. e405–13. EBSCOhost, https://doi.org/10.1016/j.clml.2021.12.009.

APA

Abello, V., Mantilla, W. A., Idrobo, H., Sossa, C. L., Salazar, L. A., Pena, A., Herrera, J. M., Guerrero, P., Espinosa, D., Quintero-Vega, G. E., Munevar, I., Galvez, K., Henao, A., Gómez, R., Saavedra, J. D., Gaviria, L. M., Osuna, M., & Mateos, M. V. (2022). Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study. Clinical Lymphoma, Myeloma & Leukemia, 22(6), e405–e413. https://doi.org/10.1016/j.clml.2021.12.009

Chicago

Abello, Virginia, William Armando Mantilla, Henry Idrobo, Claudia Lucia Sossa, Luis Antonio Salazar, Angela Pena, Juan Manuel Herrera, et al. 2022. “Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study.” Clinical Lymphoma, Myeloma & Leukemia 22 (6): e405–13. doi:10.1016/j.clml.2021.12.009.